Sutro Biopharma, Inc. (STRO) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$22.34
Day's range
$26.21

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
05/28/2026 Barclays Lukas Shumway $56.00 $29.69   88.62%
05/15/2026 H.C. Wainwright Andrew Fein $50.00 $38.42   30.14%
10/11/2024 Bank of America Securities Tazeen Ahmad $12.00 $36.05   -66.71%
10/11/2024 H.C. Wainwright Andrew Fein $12.00 $36.10   -66.76%
08/16/2024 Truist Financial Asthika Goonewardene $15.00 $42.10   -64.37%
05/14/2024 Deutsche Bank James Shin $10.00 $43.40   -76.96%
05/14/2024 Wedbush David Nierengarten $8.00 $42.30   -81.09%
04/03/2024 Oppenheimer Jay Olson $10.00 $50.90   -80.35%
04/03/2024 Piper Sandler Edward Tenthoff $11.00 $50.90   -78.39%
04/02/2024 Truist Financial Asthika Goonewardene $18.00 $50.90   -64.64%
06/28/2022 Piper Sandler Edward Tenthoff $16.00 $50.50   -68.32%

Sutro Biopharma Inc FAQ's

Sutro Biopharma Inc has been rated by research analysts at Truist Financial, Barclays, Wedbush, H.C. Wainwright, Leerink Partners, Mizuho Securities in the past 90 days.